EBARA JITSUGYO Co., Ltd. (6328): A Good Business on a Rented Moat, at a Price That Leaves No Room
- Stamp
- 2026-07-21
- Price
- ¥2,354
- Market cap
- ¥566oku
- Buffettwatchbuy < ¥1,850
- Mungerwatch—
- Pabraiwatchbuy < ¥1,250
- Li Luwatchbuy < ¥1,650
- Claudewatch—
Verdicts
| Lens | Verdict | Buy below | Most load-bearing items |
|---|---|---|---|
| Buffett | watch | ¥1,850 | B92/B89/B93; B23/B25 |
| Munger | watch | — (conditional ~¥1,800–2,000) | M18; M82; M44 |
| Pabrai | watch | ¥1,250 | P53; P18/P56; P1 |
| Li Lu | watch | ¥1,650 | L1; L18/L5; L48 |
| Claude | watch | implied ¥1,600 | C35; C40/C9; C33 |
All five lenses independently reached watch — the batch's FIRST unanimous non-decline after nineteen studies, and the first name to clear the quality bar every deep-value name failed. The shared finding: this is a genuinely good business — durable 15–17% ROE [F47–F51], net cash +¥13,646M , asset-light , owner-friendly (payout 35%→40% [F322/F323] + a ¥1bn buyback ), with an activist on the register — offered at 2.01× book / 12.78× earnings , which is fair, not cheap, and so carries no margin of safety. The panel waits for a ~30% cheaper entry (buy-belows ¥1,250–1,850). This directly answers the batch's question — does quality at a fair price get a buy? — No: it gets a disciplined watch. The crux every lens circles: is the moat owned or borrowed — a privileged-but-terminable Ebara agency (contract auto-extends only one year past 2026-09-30 ; ~67% of merchandise purchases from Ebara [F304/D23]) plus government-budget demand (66% of sales to 官公庁 [F294/D24]) — and is FY2025 a peak (Engineering segment profit +76.8% ; management's own EJ2027 plan guides operating profit ¥6,300M→¥5,500M, FY2026→FY2027 [F411/F412])?
The business
EBARA JITSUGYO (荏原実業) sells water and environmental-infrastructure equipment in Japan, and it does three distinct things under one roof . A shopkeeper can follow it in a sentence.
The Maker segment (メーカー) designs its own gadgets — ozone-concentration meters, deodorizing units, infection-control products, aquaculture equipment, home storage batteries — and has partner factories build them; the company owns no plant of its own and is fabless . It owns the IP and the production know-how, and outsources the metal-bending. In FY2025 this segment turned over ¥7,506M of external revenue at ¥1,247M of profit — down 5% on higher personnel cost .
The Engineering segment (エンジニアリング) takes contracts directly from city and prefectural governments (官公庁) to design and build water-treatment plants, buys the pumps and materials from the Ebara Group, and subcontracts the digging to a ~70-firm partner network it calls the Ginsuikai . This is the biggest arm — ¥22,450M of revenue , ¥4,332M of profit — and it is 97% government by revenue (¥21,861M of ¥22,450M to 官公庁 ).
The Trading segment (商社) resells Ebara-Group pumps, boilers and energy-saving HVAC to private buyers, earning a distribution spread — ¥11,254M of revenue, ¥1,883M of profit [F257/F263].
Two facts sit at the center of the whole enterprise, and they are the reason the study exists. First, about two-thirds of what the company sells goes to the government: 66.3% of sales and 67.3% of orders are to 官公庁 [F294/D24, F288/D31], a budget-cycle-driven demand base with hard December-to-March seasonality [E33/E34]. Second, about two-thirds of the merchandise it buys to resell comes from one supplier — the Ebara Group (㈱荏原製作所), at 67.0% of merchandise purchases and 19.3% of product/construction COGS [F304/D23, F300/D22]. EBARA JITSUGYO has been Ebara's distribution agent (販売代理店) since July 1950 — seventy-five years of unbroken commercial relationship — and it even holds Ebara shares (¥4,036M) as its largest policy cross-holding, expressly to protect that relationship . But there is no capital tie the other way: the company owns 0.24% of Ebara Corp , Ebara owns none of it, and the filing states plainly that Ebara is not a related party and not a parent [E11/E124/E125].
This is the borrowed-moat nuance the whole panel wrestles with. Customers keep paying because water infrastructure is aging and disaster-resilience spending is rising , and because a municipal engineer specifying a new sewage plant reaches the standing, certified channel — EBARA JITSUGYO — the way he reaches a habit. But that channel rests on two things the company does not control: a government's budget, and a supplier's contract. The basic agency contract for fluid-machinery products (including engineering and incidental work) is dated Oct 1 2024 and auto-extends for only one year after 2026-09-30 ; management lists non-renewal or substantial shrinkage of the Ebara relationship as a named risk . The durability is real — seventy-five years of it — but for a decade-long owner it is rented durability, not owned. The aging-water tailwind is genuine and structural , but management itself names the counter-vector: population decline . The end-market is not the problem; whose the moat is, and how normal FY2025's earnings are, is the whole debate.
The numbers
At the ¥2,354 stamp (post the 2026-01-01 2-for-1 split ), EBARA JITSUGYO is a genuinely good business offered at a fair price — the mirror of every deep-value name on the record.
The record is durable, and this is the finding that separates the name from its predecessors. Recurring profit (経常利益) compounded ¥4,110M → ¥6,316M over five years [F6/F10], never once a loss year; return on equity ran 17.62 / 11.55 / 15.93 / 14.20 / 17.06% [F47–F51] (recomputing cleanly to 17.06% ), averaging ~15.3% with the trough at ~11.6% — a real, cyclical, un-confected series. FY2025 was a record across the board: revenue ¥41,211M (+9.9%), operating profit ¥6,121M (+44.0%), recurring profit ¥6,316M (+42.2%), net income ¥4,384M (+38.8%) [F5/F87/F10/F220, E45]. And it is earned with almost no debt. Total borrowings are ¥1,524M against ¥15,170M of cash — net cash of +¥13,646M , ~24% of the ¥56.6bn net market cap , about ¥528 a share . Equity ratio 57.7% ; interest coverage 130× . The business is asset-light to the point of comedy: investing cash flow of just −¥205M on a ¥41bn revenue base , capex ¥428M (of which ¥190M was research-lab land , i.e. growth, not maintenance) against depreciation ¥234M [F331/F233], and tangible fixed assets of only ¥3,269M . Owner earnings are close to reported net income. Strip the idle cash and the operating business earns a very high return on the tangible capital it truly uses; on the whole book the ROIC proxy is ~14.8% .
The valuation is fair, not cheap — the exact opposite of a margin-of-safety bargain. P/B = 2,354 ÷ split-adj BPS ¥1,172.56 = 2.01× ; P/E = 2,354 ÷ split-adj EPS ¥184.24 = 12.78× ; dividend yield ¥60.00 ÷ 2,354 = 2.55% ; EV ≈ ¥43.0bn , EV/経常 ≈ 6.8× on the peak recurring line (but ~9.8× on mid-cycle recurring). Graham would walk right past it — net current assets are roughly ¥569 a share (current assets ¥35,168M less all liabilities ¥20,443M [F161/F166]) against a ¥2,354 price, about four times covered; this is not a net-net, and the net cash, though real, is only ~22% of the price. At 2× book there is no asset floor doing the analyst's work; the whole case rests on the quality holding up.
The record year leans on one lumpy segment, and management guides the peak down. The +44% jump in operating profit came almost entirely from Engineering segment profit +76.8% (¥2,450M → ¥4,332M) [D25/F260/F261], which the MD&A attributes to a high opening order backlog converting on schedule — timing, not run-rate . Maker was down 5% and Trading up 8% [F259/F263]; strip the backlog conversion and there is no record. The incremental operating margin FY2024→25 was ~50% — far above the ~14.9% average — which reads "earnings high," not "moat widening." Management's own EJ2027 plan then puts operating profit at ¥6,300M (FY2026) → ¥5,500M (FY2027) [F411/F412] — declining — with the plan-period operating margin guided to 12.2% , below the 14.9% just booked ; FY2025's ¥6,121M already exceeds the FY2027 plan. And the headline yield is flattered: FY2025's ¥120 pre-split DPS includes a ¥20 80th-anniversary commemorative (¥10 interim + ¥10 year-end) [F324/E74], so the recurring post-split yield is ~2.1%, not 2.55%. Cash conversion was lumpy this year — operating cash flow ¥1,413M against net income ¥4,384M [F61/F220] — because trade receivables and contract assets rose ¥3,157M as the Engineering backlog converted (contract assets ¥7,856M → ¥11,128M ); a benign, disclosed percentage-of-completion timing feature — the sole Key Audit Matter — not an accrual game, but a reason to normalize earnings down.
The five lenses
Buffett — watch
Let me tell you what this company actually does, because that is where every one of these decisions starts. Ebara Jitsugyo sells water and environmental equipment in Japan, and it does three things under one roof — it designs its own gadgets and has other people build them , it takes contracts straight from city and prefectural governments to design and build water-treatment plants , and it runs a little trading desk reselling Ebara equipment . Two facts sit at the center: about two-thirds of what it sells goes to the government [F294/D24], and about two-thirds of the merchandise it buys comes from one supplier, Ebara Corp [F304/D23]. A shopkeeper could follow that in a sentence, so the circle-of-competence gate opens — I understand how the cash gets in the door.
The record is the kind I like to look at. Recurring profit went from ¥4,110M to ¥6,316M over five years [F6/F10], never once losing money, and return on equity has run 17.6, 11.6, 15.9, 14.2, 17.1 percent [F47–F51] — good returns, and here is the part that matters, earned with almost no debt. The whole balance sheet carries ¥1,524M of borrowings against ¥15,170M of cash — roughly ¥13.6bn of net cash , about ¥528 a share , equity ratio 57.7% . It throws off cash without needing to eat much — depreciation ¥234M against a capital budget of ¥428M, and ¥190M of even that was buying land for a research lab, not staying in business [F233/F331/E61]. That is not a good business; that is a very good business hiding behind a fortress balance sheet.
Now, what would I pay, and what does the market ask? It asks ¥2,354 — two times book and about thirteen times earnings . My old teacher Ben Graham would have walked right past this: net current assets are about ¥569 a share [F161−F166] against the price, four times covered, nowhere near a net-net. This is not a cigar butt. If I buy it, I am buying a good business at a fair price, and the whole case has to rest on the quality holding up — because at 2× book, there is no asset floor doing my work.
So I have to be honest about the quality, and here I get uneasy. A genuine franchise is something customers need, can't easily substitute, and where nobody sets your price [B23]. Two-thirds of this business is selling to government bodies whose budgets can be squeezed and whose contracts are competitively bid — a customer relationship, not pricing power. And the moat I can actually point to isn't Ebara Jitsugyo's at all — it's the Ebara agency contract [E3/E57], which gives them the products to sell, and which auto-renews but expires September 2026 and only extends one year at a time thereafter . A moat you rent from someone else, on a one-year rollover, is not the enduring kind I want to own for a decade without a quote. It has held for seventy-five years, which counts for a great deal — but I cannot underwrite it as if the company controls it, because they don't. The record this year sharpens the worry: the whole jump in profit came from one segment — Engineering profit up 76.8% on a backlog burning off — and management's own plan guides operating profit down the next two years [F411/F412]. I'd value it on the cycle, not on the peak. And the founder, born 1939, is both Chairman and CEO at 86 — a succession question I cannot wave away.
Here is where I come out. This is a genuinely good, understandable business, conservatively financed, run by people who tell the truth and treat owners fairly — a payout raised 35%→40% and a billion yen of buyback [E73/E72]. But it is offered at a fair price, not a cheap one — an owner-earnings yield around 7.7% on the net market cap , which is fine, not fat, and the durable edge underneath it is a rented agency contract and a government-budget customer base. When the quality is arguable and the price is merely fair, I don't swing — there are no called strikes. I'd want this at a price where the owner-earnings yield reaches double digits and I'm paying closer to 1.6× book — around ¥1,850 — which also buys me a margin of safety against the day the Ebara contract or the government budget disappoints. Until then, I watch.
What a student should take from this: when the business is good but the moat belongs to somebody else — a supplier's contract, a government's budget — you are renting the durability, not owning it, and you must price for the day the lease ends. A fair price for a genuinely good business is a watch, not a buy; the discount, not the quality alone, is what protects you when the thing you can't control finally moves against you.
Munger — watch
Invert first, as always. How does this business die? The obituary writes itself in one paragraph: Ebara Corporation — the source of two-thirds of EJ's merchandise-purchase cost [D23/F304] and the dominant equipment supplier — declines to renew its agency contract, which it can do on one year's notice after September 2026 . EJ owns 0.24% of Ebara Corp ; Ebara owns none of EJ . The capital relationship is nil; the commercial relationship is everything. Kill path two: a Japanese public-works austerity cycle — two-thirds of sales are to public bodies , and the Engineering segment that drove FY2025's 76.8% surge is 97% public-sector [E121/F274]. Kill path three: an 86-year-old founder who is simultaneously Chairman and CEO , holding relationship capital an org chart cannot transfer.
Now the business, plainly stated. EJ is a privileged distribution agent for the Ebara Group [E7/E11]. It does not make pumps; it sells them, installs water infrastructure for municipalities, and runs a smaller trading book. The moat has two distinct layers, and I must not conflate them. Layer one, the Ebara relationship — seventy-five years of unbroken commercial entanglement , a conditioned reflex where the public engineer specifying a plant reaches EJ the way he reaches his dentist. This is close to a franchise, but it is a borrowed one: the brand belongs to Ebara Corp, not EJ. Layer two, the Maker segment's own IP — ozone meters, PFAS filtration, storage-battery flood-gates — genuine EJ inventions, but small (¥1,247M of profit, down 5% ).
The figure table is genuinely good: five-year ROE 17.6 / 11.6 / 15.9 / 14.2 / 17.1% [F47–F51], the FY2022 dip to 11.6% showing this is real and cyclical, not confected. Net cash ≈+¥13,646M against ¥1,524M of borrowings [D14/F171], interest coverage 130× , investing cash flow −¥205M on a ¥41bn base . No bonds, no lease debt, no Level 3 mysteries; the non-trivial items — the Ebara stake at ¥4,036M and contract assets ¥11,128M — are transparent, and the Deloitte KAM zeroes precisely on the over-time revenue estimates with an unqualified opinion [E134/E137]. Incentives are the right three metrics — consolidated OP, net income, ROE — no EBITDA theatre, no options , founder skin in the game at 2.48% . The activist (Nippon Active Value Fund 7.58% ) and the payout upgrade to 40% plus the ¥1bn buyback keep the board focused on per-share value.
But what inflated FY2025 was Engineering profit +76.8% on a high opening backlog delivering on schedule — timing, not a permanent step-change. FY2025 is a record made partly by construction timing, and management's own EJ2027 plan guides operating profit ¥6,300M → ¥5,500M, FY2026→FY2027 [F411/F412], with margin to 12.2% . Strip the ¥20 commemorative dividend and the sustainable yield is ~2.1%, not 2.55% . The load-bearing question is whether the Ebara agency is a durable privileged position or a revocable license — seventy-five years of renewal is strong evidence ; zero capital tie is the perpetual risk. I cannot put a decade-horizon compounding thesis on a contract that renews annually after 2026. At P/E 12.78× on peak-cycle EPS, the market is pricing continued elevated Engineering margins; normalize Engineering toward its FY2024 level and consolidated OP is nearer ¥4.5bn, an EV/OP around 9.5× on normalized earnings — more than fair, not a bargain.
The verdict is watch. The business quality is genuine, the price is not clearly wrong, but the founder transition is a known unknown, the Ebara renewal is a dated cliff, and FY2025 earnings are elevated by construction timing. At a price that discounts a normalization and removes the commemorative dividend — something in the ¥1,800–2,000 range on normalized EPS of ~¥150 at 12–13× — this becomes a candidate. At ¥2,354 on peak-cycle figures (12.78× ), patience is the rational posture. There is nothing more to add until the contract renews past 2026, a succession event is disclosed, and Engineering normalizes without a profit collapse.
What a student should take from this: the borrowed-moat problem is the central lesson. When a firm's returns depend on a revocable commercial contract with a more powerful principal — however long it has run — you are not buying a franchise, you are buying a temporary license dressed in franchise statistics. The ROE and the margin look like a Wrigley; the contractual structure is closer to a car dealership. Distinguish between the moat the figures describe and the moat the legal structure protects; here both are real, but only one is unambiguously durable.
Pabrai — watch
Start where Dhandho always starts: what do I lose if I am wrong? Heads I win; tails I don't lose much. Only after that do I let myself look at the upside. The balance sheet here is the kind I like to find in Japan — cash and deposits ¥15,170M against total borrowings of ¥1,524M , no bonds, no lease debt, leaving net cash of +¥13,646M , about ¥528 a share ; equity ratio 57.7% , interest coverage 130× . On top of the cash sit listed securities: the ¥4,036M Ebara stake plus pure-investment names carrying a ¥3,800M unrealized gain — call it ~¥8.2bn of marketable stock. Before I value the operating business at one yen, I have roughly ¥20bn of liquid assets against a ¥56.6bn net market cap — ~36 cents of every purchase yen sitting in cash and quoted stock. This is the IKEA-never-took-debt profile: this company simply cannot be killed by a lender's mood. The whole survival family passes without a fight — two lost years would leave it still cash-rich, still paying dividends, still buying back stock.
So the "tails" branch is real and hard. But here is the discipline: an asset floor is not the same as a fifty-cent dollar. At ¥2,354 the stock trades at 2.01× book and 12.78× earnings , EV/経常 6.8× . My hard floor — net cash plus haircut securities — is maybe ¥900–1,100 a share; book value is ¥1,172 . If the market re-rated to its asset backing, I'd lose roughly a third to a half. That is not "I don't lose much" — the downside is cushioned, not absent.
Now the business, in five plain sentences (P50). EBARA JITSUGYO builds water-treatment plants for Japanese governments (~66% of sales to 官公庁 ), sells self-designed environmental gear it has contract-manufactured because it owns no factories , and trades Ebara-Group pumps to private buyers. It is the distribution agent for Ebara Corp , buying ~67% of its merchandise from that group . Customers stay because water infrastructure is aging and disaster-resilience spending rising . That clears the circle-of-competence gate on simplicity, and it is a slow-changing industry — a sewage plant in 2005 looks like a sewage plant today.
The load-bearing worry is P18 — cyclical trough vs. what I'm actually being handed, which is the opposite: a record year. FY2025 was the best in the company's history — 経常利益 ¥6,316M versus ¥4,110M four years earlier — driven almost entirely by Engineering profit +76.8% [D25/F261] on a high opening backlog burning off . I am not buying a distressed business in a distressed industry; there is no fire in this theater, no fearful seller. The ROE series dropping to 11.6% in FY2022 and 経常 to ¥2,929M proves the stream breathes; value the company on a mid-cycle ¥4.5–5.0bn and 13× trailing is really ~16–18× normalized. That is fair value for quality, not a bargain. What I am paid to wait (P17) is genuine — net cash compounding, a dividend (though ¥10 of it is an 80th-anniversary one-off , so the durable yield is ~2.1%), a payout rising 35%→40% [F322/F323], a fresh ¥1.0bn buyback , and a real activist on the register (Nippon Active Value Fund 7.58% ). But the excess returns come from an incumbent Ebara agency whose basic contract expires 2026-09-30 with only a one-year auto-extension ; the two-sided concentration (67% of purchases from one group ; 66% of sales to budget-constrained governments ) is exactly what P12 flags.
Verdict: watch. The downside is cushioned by a hard net-cash-and-securities floor (net cash +¥13,646M ), so this is not a pass — nothing here can permanently impair capital. But the discount is not wide enough for a big Dhandho bet, and I'm being asked to pay a full multiple on peak earnings. Few bets, big bets, infrequent bets: this one doesn't clear the bar at ¥2,354. It clears it in the ¥1,000s — I'd be a confident buyer near ¥1,250, where net cash and securities cover most of the price and I'm buying the water franchise nearly for free.
What a student should take from this: a fortress balance sheet answers "will I go to zero?" — it does not answer "am I buying a fifty-cent dollar?" Those are two different questions, and a hard asset floor at roughly two-fifths of the price is a reason not to pass, not a reason to buy. The second lesson is the trap of the record year: when the cheapness is measured against peak earnings driven by one segment burning off a high backlog, normalize before you pay, or you will mistake the top of a cycle for the floor.
Li Lu — watch
Let me begin where I always begin: not with the price, but with whether I can honestly say I understand this business's next ten years better than most of the people who own it. Everything downstream — the two-times-book, the thirteen-times-earnings, the fortress balance sheet — is idle until that question is answered, because no price rescues a business you cannot predict.
The business is unusually legible, which I respect. Ebara Jitsugyo sells and builds water and environmental infrastructure through three segments — a fabless Maker , an Engineering arm taking public-sector orders directly , and a Trading arm — and it is a distribution agent for the Ebara Group . The economics are genuinely good and durable on the face of the record: ROE 17.6 / 11.6 / 15.9 / 14.2 / 17.1% over five years [F47–F51], recurring profit compounding ¥4,110M to ¥6,316M [F6/F10], equity ratio 57.7% , net cash ~¥13.6bn against a ~¥56.6bn net market cap . Investing cash flow of −¥205M tells you this earns its returns on almost no plant. The auditor has been Deloitte continuously since 1984, unqualified, no going-concern doubt, the single KAM the percentage-of-completion accounting [E94/E134/E137]; no related-party transactions , Ebara explicitly not a parent .
So can I predict the earnings ten years out (L1)? The decisive variables are two. First, the public-sector water-infrastructure spend — ~66% of sales, ~67% of orders to 官公庁 [D24/D31] — which management itself frames as two opposing vectors, aging-infrastructure and resilience pulling up, population decline pulling down [E24/E23]. Second, the Ebara agency — ~67% of merchandise purchases Ebara-sourced , under a basic contract that "auto-extends only one year after 2026-09-30" . I can map each variable to a disclosure — that part of L1 passes. What I cannot do is answer them with the confidence my standard demands. The demand is a government budget line the company neither controls nor prices; the Ebara contract is the hinge of the whole enterprise, and the filing gives me a renewal date, not a renewal guarantee. That forces the honest ledger (L4): two load-bearing inputs are assumptions, not verified facts, and at 2× book with a cash-heavy balance sheet the price does not pre-absorb a bad resolution of either (L5). This is not Timberland, where the feared exposure was under 5% of earnings and the stock was priced for disaster; here the feared exposures are the majority of revenue, and the stock is priced for a good, well-run compounder — fairly, not fearfully.
Now the compounding case, because it is why this is a watch and not a pass. Is intrinsic value growing or melting (L35)? Growing: book value per share compounded ~10.6% p.a. , the ROIC proxy sits near 14.8% and higher stripped of idle cash, and management's capital allocation is the virtue I prize most — payout raised 35%→40% , a ¥1.0bn buyback , no empire-building goodwill, eighty years inside its circle. The four-part gate (L50): superior company economics yes; superior industry economics only partly (public works is stable but not a great business, and the Engineering swing that drove +76.8% was backlog timing , not a moat step-change); good management yes, on the action trail; right price not yet. Quality wrinkles too: FY2027 operating profit is guided below FY2026 in the company's own plan [F411/F412], and operating cash flow was ¥1,413M against ¥4,384M net income [F61/F220] because contract assets swelled ¥3,157M — real profits, lumpy cash. And the key-man fact I will not wave away: the founder, born 1939, is Chairman and CEO , with a President/COO born 1962 beneath him .
Verdict: watch. The knowledge bar bars a buy and would push toward too-hard were the business not so clean and the downside so bounded — which is what pulls it up to watch. A concentrated position is warranted only below a price that pre-absorbs a bad resolution of the unknowns — well under the 2.01× book the market asks — I'd own it near ¥1,650, and only after the contract and succession unknowns narrow.
What a student should take from this: a clean, cheap, net-cash compounder with honest books is not automatically a buy — the knowledge bar comes first, and it is not cleared by a low multiple but by whether you can genuinely predict the business a decade out. When the two variables that decide the outcome (a government's budget and a supplier's renewable contract) are things the company does not control and you must assume rather than verify, the correct answer is a disciplined watch at a price that pre-absorbs a bad resolution — not a pass on a good business, and not a purchase you are pretending to underwrite.
Claude — watch
My figures-blind priors, registered first, held up almost verbatim: I put P(watch) at 0.35 as the single most probable landing, with the tension pre-committed — "good business, right direction of travel, but priced too close to fair value to demand today." The ledger confirmed every load-bearing prior and overturned none of the important ones. (Self-distance: I hold this verdict, built the reconciled figure table all five lenses consumed, and wrote the synthesis below — read all three with that concentration of authorship in mind.)
What the ledger confirmed. Quality is real, not a peak illusion at the ROE line — 17.62 / 11.55 / 15.93 / 14.20 / 17.06% across FY2021–25 [F47–F51], no loss year, on a 57.7% equity ratio . Net cash is a genuine cushion, the opposite of a levered residual — +¥13,646M , ~24% of the ¥56.6bn net market cap . Asset-light is confirmed to the yen — 投資CF −¥205M , depreciation ¥234M , tangible fixed assets only ¥3,269M . The moat is borrowed, my H1 gate — ~67.0% of merchandise purchases Ebara-sourced [F304/D23], the basic agency contract auto-extending only one year past 2026-09-30 , ~66.3% of sales to 官公庁 [F294/D24]. And the record year is Engineering-peak-flattered — consolidated OP +44% almost entirely on Engineering segment profit +76.8% (¥2,450M→¥4,332M) [F260/F261/D25] on "a high opening order backlog" , with management's own EJ2027 guide putting FY2027 OP (¥5,500M ) below FY2026 (¥6,300M ) — an explicit admission the peak recedes. The read on the moat is more precise than "borrowed": it is mostly rented (the selling right and the demand base both), but carries some owned elements — direct 官公庁 incumbency, the Ginsuikai network , design IP , a 75-year relationship — owned enough to earn 15%+ ROE, not owned enough to underwrite the peak as permanent.
The deciding work is the owner arithmetic. I value the whole company as a private buyer, downside first. Bear case (C33), each assumption from observed history: the FY2022 trough printed net income ¥2,169M ; un-do the Engineering peak and let margins revert to a normalized bear net income ≈¥2,400M, capitalize at 9% no-growth (¥26.7bn) plus full net cash ¥13.6bn = ¥40.3bn ÷ 24.06M net-float shares ≈ ¥1,675/share — a −29% draw, cushioned, not eliminated, by real cash. Private-owner yield (C35), multiple-free — the hinge: normalized owner earnings ≈¥3,400M against market cap net of ~¥11bn deployable cash = 7.4%, below a ~9% hurdle for a borrowed-moat, budget-dependent small-cap. Only on FY2025 peak earnings (¥4,384M) does the yield reach 9.6% and clear. That is the whole verdict in one line: the owner yield clears only if you credit the peak you were just told recedes. A reverse-DCF confirms it — at ¥2,354 the price embeds near-peak-no-growth or mid-cycle-plus-2%-growth, fair not cheap, and harder to beat than a bargain would need.
Verdict: watch. It is not a pass: the downside is real (−29%) but survivable and cash-cushioned, the capital-return trajectory is executing (payout 35%→40% [F322/F323], a ¥1bn buyback running ), and an activist sits on the register . It is not a buy here: the private-owner yield does not clear on normalized earnings, the moat is borrowed at a contract the firm does not control, and I would be paying a full price for a peak year management itself guides down. And it is not too-hard: the price question decides the verdict at ¥2,354 before the genuine unknowables (agency renewal, founder succession) become load-bearing — those are reasons for the discount I demand, which is precisely a watch. Implied buy-below ¥1,600 (bear-case owner yield clears at the hurdle; mid-cycle yields 12.4%), ~32% below the stamp, derived blind to the price.
What a student should take from this: a high ROE, a fortress balance sheet, and a rising dividend do not by themselves make a buy — the question is always at what price, and a good business bought at a fair price is a fine business and a mediocre investment. The discipline that produced the verdict was refusing to capitalize a peak: normalize earnings to mid-cycle, strip the commemorative dividend, and require the private-owner yield to clear the hurdle on that number — when it only clears on the year management is guiding you away from, the honest answer is "own it cheaper," not "own it."
Synthesis
Where the lenses agree
For the first time in the record, all five lenses reach the same verdict without a single decline — and it is the first name to clear the quality bar that every deep-value predecessor failed. The agreement is total on three facts, and they are the whole study.
First, the quality is genuine and durable. ROE ran 17.6 / 11.6 / 15.9 / 14.2 / 17.1% across five years with no loss year [F47–F51], recurring profit compounded ¥4,110M → ¥6,316M [F6/F10], and it is earned on a fortress balance sheet — net cash +¥13,646M , equity ratio 57.7% , asset-light to −¥205M of investing outflow . Every lens credits this. Buffett: "a very good business hiding behind a fortress balance sheet." Munger: "the figure table is genuinely good." Claude: "my priors under-, not over-, weighted the quality." This is not a levered residual or a melting-ice cube; it is a real, above-average business.
Second, the price is fair, not cheap — there is no margin of safety. At 2.01× book and 12.78× earnings , the panel is unanimous that the discount every deep-value name offered is simply absent. Buffett: "not a cigar butt … a fair price, not a cheap one." Pabrai: "an asset floor is not the same as a fifty-cent dollar — the downside is cushioned, not absent." Li Lu: "priced for a good, well-run compounder — fairly, not fearfully." Claude: "fair, not cheap, and harder to beat than a bargain would need." The net cash is real but only ~22–24% of the price ; NCAV is ~4× covered [F161−F166]; the operating business is not being handed to you at a discount.
Third, the record year is a peak, and management says so in writing. FY2025's +44% operating-profit jump is almost entirely Engineering segment profit +76.8% [D25/F261] on a high opening backlog converting on schedule — timing, not run-rate. Maker fell 5%, Trading rose 8% [F259/F263]. And management's own EJ2027 plan guides operating profit ¥6,300M → ¥5,500M, FY2026→FY2027 [F411/F412], margin to 12.2% . Every lens normalizes the peak down; every lens strips the ¥20 commemorative dividend to a recurring ~2.1% yield. This is the panel's operating-line discipline catching a flattered headline — the same discipline that caught one-off-flattered "records" earlier in the batch.
Where the lenses diverge
The verdict is unanimous, but the buy-below spread is wide — ¥1,250 to ¥1,850, a ~48% range — and the spread is not noise. It is three different definitions of the discount required, each driven by a specific item.
Pabrai anchors to the net-cash floor (¥1,250, the lowest). His P1 asks what he loses if wrong, and his answer is a hard asset floor — net cash plus haircut securities, ~¥900–1,100/share — that makes this not a pass. But P53 (the fifty-cent dollar) then demands he buy near that floor, "where net cash and securities cover most of the price and I'm buying the water franchise nearly for free." His discipline is the strictest on price because his floor is the most concrete: he will pay up only when the balance sheet does almost all the work. That drives the deepest buy-below on the panel.
Buffett prices the franchise, not the floor (¥1,850, the highest of the numbered belows). His crux is B23/B25 — is there a nameable barrier the company owns? — and his answer is no: the moat is the rented Ebara agency plus budget-bound demand . So he does not demand a net-cash floor; he demands an owner-earnings yield that reaches double digits and ~1.6× book, "which also buys me a margin of safety against the day the Ebara contract or the government budget disappoints." He is paying for a good business, so he pays more than Pabrai — but he insists on the discount that a rented moat, not a floor, requires.
Li Lu prices the knowledge bar (¥1,650, in between). His L1 gate is neither the floor nor the franchise price but predictability: he can map the two decisive variables (the government budget, the Ebara contract) to disclosures, but cannot answer them "with the confidence my standard demands." His buy-below is the price that "pre-absorbs a bad resolution" of unknowns he cannot verify — a knowledge-discount, landing between Pabrai's asset-floor discipline and Buffett's franchise price.
Claude (implied ¥1,600) and Munger (~¥1,800–2,000) bracket the middle by the same normalization route — the price at which the normalized (not peak) owner yield clears a 9% hurdle. Claude's C35 is the sharpest statement of the shared crux: "the owner yield clears only if you credit the peak you were just told recedes." Munger reaches the same number from EV/normalized-OP (9.5×). The gap across the whole panel, then, is not whether to wait but how deep the discount must be — and that depends entirely on whether you protect yourself with the asset floor (Pabrai), the franchise price (Buffett), the knowledge margin (Li Lu), or the normalized-yield hurdle (Claude/Munger). All five agree ¥2,354 — 12.78× peak earnings — is a watch; all five would own it ~30% lower.
The red team, engaged
Because five lenses converged on watch (a unanimous non-decline), a fresh adversary (ledger only) argued the stronger PASS case — that ¥2,354 (2.01× book ) is not a "wait for cheaper" but a "drop it from the list," because the quality on display is borrowed, peaked, and flattered, so no future price reliably converts this into a sound minority holding. The synthesis must meet its strongest points by name. Each sharpens the crux; none breaks watch down to pass, and here is why.
"The moat is not owned — it is rented, and the lease has a date on it." The bear's central point, and it is true as stated. EJ is a fabless distribution agent buying 67% of merchandise from Ebara [D23/F304] under a contract that auto-extends only one year past 2026-09-30 , with non-renewal a named risk . But this is precisely the crux the whole panel already priced — it is why the buy-belows sit 30–48% below the stamp. The rebuttal to pass is that a rented moat is a reason to demand a discount, not a reason to declare the business un-ownable at any price: seventy-five years of unbroken renewal , a two-sided anchor (EJ holds ¥4,036M of Ebara stock to protect the tie ), and the 15–17% ROE it has actually produced [F47–F51] mean the relationship is durable enough to own — at a price. The bear proves the moat is rented; it does not prove the rent will be called.
"FY2025 is a peak — management says so in writing." Fully conceded, and the panel conceded it first. EJ2027 guides OP ¥6,300M → ¥5,500M [F411/F412], and FY2025's ¥6,121M already beats the FY2027 plan. This is exactly why every lens normalizes down and none pays 12.78× the peak. But a peak-year print is a reason to value on the cycle, not to conclude the through-cycle business is worthless — and the through-cycle record here is genuinely good (no loss year, ROE trough at 11.6% ), unlike the loss-ridden cyclicals the batch declined. The guide-down caps the price you pay; it does not zero the franchise.
"The record is un-cashed backlog — operating cash flow fell to ¥1,413M as contract assets ballooned +¥3,157M." Conceded on the facts [F61/F235] — and it is the reason the panel trusts the record less than the headline. But the driver is benign and disclosed: percentage-of-completion timing on Engineering backlog converting , the sole KAM the auditor examined and passed unqualified [E134/E137], not accrual manipulation. Cumulative five-year cash conversion is ~80%, below 90% but not alarming. It argues for normalizing earnings down — which the panel did — not for a pass.
"An 86-year-old founder is Chairman and CEO — an undated, unpriced key-man discount." Conceded, and named by every lens . Munger and Li Lu both flag it as the concrete near-term risk. But a capable President/COO is in place , the Nomination Committee monitors succession , and — decisively for pass vs watch — it is a reason for the discount the panel already demands, not a fact that makes the business un-ownable. Succession risk is priced by waiting, not by dropping.
"There is no reachable discount even at the watch price — the cash is inert, the activist has not forced a re-rating." This is the bear's real challenge to watch itself, and it is the honest tension. The rebuttal: the net cash is a genuine downside cushion whether or not it is activated (~24% of cap ), the capital-return trajectory is executing (payout 35%→40% , a ¥1bn buyback with ¥62M already bought by the filing date ), and the register is contestable, not management-locked . The bear is right that a lower price does not fix a rented, guided-down franchise — but the panel never claimed it would; the buy-belows assume the bear case (normalized earnings, no re-rating) and simply demand to buy the good-through-cycle business at a price where the normalized yield clears. The bear's own falsifier — sustained OP ≥¥6bn at ≥13% margin beyond the backlog year, beating the guide-down — is the same observable the panel is waiting on.
The red team did not move any verdict off watch, but it earned its keep: it is why the synthesis states the crux as sharply as it does — is the moat owned or borrowed, and is FY2025 a peak? The honest resolution is that both facts are true (the moat is rented; the year is a peak), and both are reasons for the ~30% discount the panel demands rather than reasons to declare the business uninvestable. The net cash (+¥13,646M ) and the genuine, no-loss-year, durable-ROE history (ROE floor 11.55% ) keep it a watch, not a pass: a good business, correctly priced as fair, worth owning ~30% cheaper — not a value trap to discard.
Self-distance note. The Claude lens holds one of the five verdicts compared above (watch) and wrote this synthesis; it also built the dual-blind reconciled figure table and evidence ledger all five lenses consumed, and the red-team ran on the same model family. That is an unusual concentration of authorship — the answerer, the ledger-builder, one of the five voters, and the adversary are the same system. Read the synthesis with that in mind.
Prediction-vs-actual: VOID. This was an autonomous headless cycle; the human blind prediction is voided (void: no-human-prediction, never forged). No prediction-vs-actual scoring applies.
Verdict accounting (fixed ex-ante)
- A buy-below-¥X verdict is price-falsifiable against the unadjusted stamp. Three lenses issued explicit buy-belows — Buffett ¥1,850, Pabrai ¥1,250, Li Lu ¥1,650; Claude publishes an implied buy-below of ¥1,600; Munger's is a stated conditional range (~¥1,800–2,000), not a hard number.
- pass / watch / too-hard are recorded but unscored in any future review. All five verdicts here are watch; the buy-belows sit below the ¥2,354 stamp and are the price at which each lens would revisit toward buy.
- The original verdict counts at its original stamp regardless of later corrections.
- On a stock split, reverse split, or consolidation, the buy-below threshold restates mechanically by the announced ratio (corporate-action disclosure cited); the stamp itself never restates. (The ¥2,354 stamp already reflects the 2026-01-01 2-for-1 split ; all buy-belows are stated on the post-split basis.)
Red team
A consensus red-team (five of five lenses converged on watch, a unanimous non-decline) was dispatched to argue PASS — that ¥2,354 / 2.01× book is not a "wait for cheaper" but a name to drop, because the FY2025 quality is borrowed (a terminable Ebara agency), peaked (by management's own guide-down), and flattered (a commemorative dividend + a backlog-timing profit spike), so no future price reliably makes it a sound minority holding. Its strongest points, verbatim-faithful, and the synthesis's engagement with each, are in "The red team, engaged" above. In brief, the adversary's five ranked points were: (1) a borrowed moat with a dated expiry — 67% of purchases from Ebara [D23/F304], contract auto-renewing only one year past 2026-09-30 ; (2) management's own EJ2027 plan says FY2025 peaked — OP guided ¥6,300M → ¥5,500M [F411/F412]; (3) the record is un-cashed backlog — operating cash flow fell to ¥1,413M as contract assets rose +¥3,157M [F61/F235], the sole KAM ; (4) an 86-year-old founder is both Chairman and CEO ; (5) the dividend record is one-off-flattered by a ¥20 commemorative . The synthesis concedes every factual point — the moat is rented, the year is a peak, the cash conversion was lumpy, the founder is 86, the dividend was flattered — and meets the load-bearing claim (that these make the business un-ownable at any price) by the reachability-of-the-discount test: each fact is a reason for the ~30% discount the panel already demands, not a reason to declare a no-loss-year, net-cash, durable-ROE business uninvestable. The bear's own falsifier (sustained OP ≥¥6bn at ≥13% margin beyond the backlog year, beating the guide-down [F411/F412/E21]) is the same observable the panel is waiting on. A consensus that faced its strongest opponent and emerged intact — sharpened on the crux (owned vs borrowed moat; peak vs plateau), unmoved on the verdict.
What would change our minds
Pre-registered falsifiers, per lens issuing a buy-below or holding the watch. The verdicts converge on a single observable: does the recurring earning power hold on a NORMAL (non-peak) year at a full tax charge, and does the Ebara agency renew / does founder succession resolve — versus the price simply falling into the ¥1,250–1,850 range.
- Buffett (watch, buy-below ¥1,850). Toward buy: a price near ¥1,850 (owner-earnings yield ~10%, ~1.6× book) clears the margin-of-safety bar [B93]. Toward too-hard: if the basic Ebara agency contract is not renewed, materially re-priced, or narrowed, OR the ¥13.6bn net cash is deployed into a full-priced acquisition rather than returned or reinvested at the historical ~15% ROE — the quality case that justifies paying ~2× book collapses.
- Munger (watch, conditional ~¥1,800–2,000). The falsifier is durability: sustainable recurring profit at or above ¥5.0bn for two consecutive years WITHOUT the ¥20 commemorative DPS and WITHOUT an exceptional Engineering backlog conversion (Engineering segment profit staying above ¥3.0bn even in a lean-backlog year), confirming the moat is the relationship and the operator rather than a one-cycle backlog flush .
- Pabrai (watch, buy-below ¥1,250). Broken by cyclicality proving the record a peak: two consecutive years of falling public-sector orders OR Engineering segment profit reverting below ~¥2,450M . Second falsifier: the Ebara basic agency contract not renewed or materially narrowed — the fabless/agent model loses its supply spine.
- Li Lu (watch, buy-below ¥1,650). The Ebara contract not renewed on comparable terms, OR the ~66–67% public-sector mix [D24/D31] contracting as a bloc — either severs the two variables that decide the ten-year earnings power. Concretely: a renewed contract on materially worse economics, or consolidated 官公庁 orders falling for two consecutive years, flips this from watch to too-hard.
- Claude (watch, implied buy-below ¥1,600). A price at/below ~¥1,600 upgrades toward buy [C44]. Conversely, a materially unfavourable renewal of the Ebara agency at its ~2026-09/2027 expiry moves it toward pass/too-hard; and Engineering segment profit sustaining near the FY2025 ¥4,332M peak through FY2027, contradicting management's own guide [F412<F411], would break the "own it cheaper" framing toward buy.
The single observable most lenses converge on is whether the recurring (ordinary) line compounds on a NORMAL, full-tax year — the difference between a genuine plateau and a one-off-flattered peak [F411/F412] — together with whether the Ebara agency renews on comparable terms and founder succession resolves — versus the price falling to the ¥1,250–1,850 range where each lens's discount is satisfied.
What this taught the checklists
Queued for the next study (F2 revision proposals; see docs/process/evolution.md), attributed per lens:
- Buffett — add a "rented-moat / third-party-dependence" item to the Business-economics section. B23–B31 test whether a moat exists and endures, but none directly asks: is the durable advantage owned by the company or licensed from a counterparty (supplier agency, franchise grant, sole-distributor contract) on renewable terms? Here the entire above-market return leans on the Ebara agency , yet the existing items let it score "moat present" (returns are real ) without forcing the question of whose moat it is. Also: B26/B60 should prompt an explicit ex-cash operating-ROIC re-strike when the balance sheet is cash-heavy — reported ROE understates the operating business once ¥13.6bn idle cash is removed.
- Munger — M18a (agent-dependency flag): add a sub-item to M18 distinguishing "owned franchise" from "privileged agency" — where the moat depends on a commercial contract with a more powerful principal, require stating the contract terms, renewal cadence, and what the principal loses by terminating, because the ROE fingerprint is identical between a true franchise and a contractually dependent agent. M82a (named-succession-plan requirement): tighten M82 to require not just evidence of succession planning but a disclosed, dated transition timeline where the CEO is over age 75 — this company shows the machinery can exist (active committee , identified successor ) without a disclosed timeline.
- Pabrai — add a "quality-at-fair-price is a watch, not a buy" branch to Verdict guidance: a hard asset floor (P1 pass) combined with a full multiple on peak earnings (P18/P56 fail) is a distinct shape — the floor makes it not-a-pass, the peak-multiple makes it not-a-buy; a one-line note that "a fortress balance sheet answers P1 but never substitutes for P53" would sharpen the boundary. And P56 should ask for a segment-level peak flag — here the record was one segment (+76.8% Engineering ) masking flat Maker/Trading; normalizing the driving segment against its own history catches the peak faster than the consolidated line.
- Li Lu — L1/L34 interaction, a "renewable-contract moat" sub-test: where the barrier is contractual rather than a statutory license (L34) or a switching-cost lock-in (L43), the item must locate the contract's term and renewal history and treat an imminent renewal as an unknown that lowers the L1 knowledge grade — not as a moat. And an L48 lumpy-working-capital caveat: for percentage-of-completion EPC businesses, single-year CFO/NI can diverge sharply on contract-asset swings without signaling accrual games — compute the multi-year cumulative conversion and flag contract-asset growth vs revenue growth specifically.
- Claude — two checklist sharpenings, plus a library seed. (1) A new item, "borrowed-vs-owned moat, sized": force a discrete computation of supplier/franchise dependence × contract term to expiry (67%-of-purchases × a dated agency expiry ), rather than distributing the inference across three items. (2) Sharpen C40 (cycle-position) to require management's own forward guide as a cross-check — the FY2027<FY2026 OP guide [F412<F411] was the single cleanest confirmation FY2025 is a peak, and it lives in the plan table, not the cycle history. Library (Class-level) — a new corner, the mirror of the deep-value/levered corners: "durable-return, net-cash, asset-light distribution-agent / public-EPC-integrator with a borrowed moat, priced fair-to-full." First member EBARA JITSUGYO (6328), N=1. Class definition: 15%+ through-cycle ROE with no loss year, net cash ~20%+ of market cap, fabless/subcontracted, where the selling right is a third-party agency contract and the demand base is a government budget (both rented), with an activist on the register and a founder key-man, at ~2× book / low-teens earnings. Outcome on the class's key axis (does the private-owner yield clear the hurdle at a full price?): No — at 2.0× book / 12.8× peak earnings [D1/D2] the normalized owner yield was ~7.4% [C35] vs a ~9% hurdle, clearing only on the peak; verdict watch, implied buy-below ~32% below stamp. Where the deep-value/levered corners ask whether a discount closes, this corner asks whether a fair price is worth paying — the mirror image, and it needs its own base rate: for good-but-rented-moat compounders at a fair price, how often does the market later offer the ~30% discount at which the owner yield clears?
Corrections
The five lenses, in full
Each master's complete memo — the independent reasoning behind the verdict.
Buffett
watch · buy < ¥1,850Let me tell you what this company actually does, because that is where every one of these decisions starts. Ebara Jitsugyo sells water and environmental equipment in Japan, and it does three things under one roof . It designs its own gadgets — ozone meters, deodorizers, storage batteries — and has other people build them, owning no factories itself . It takes contracts straight from city and prefectural governments to design and build water-treatment plants, buys the pumps and pipes from the Ebara Group, and hires specialists to do the digging . And it runs a little trading desk reselling Ebara equipment to private customers . Two facts sit at the center of the whole thing: about two-thirds of what it sells goes to the government [F294/D24], and about two-thirds of the merchandise it buys to resell comes from one supplier, Ebara Corp [F304/D23]. A shopkeeper could follow that in a sentence. So the circle-of-competence gate opens — I understand how the cash gets in the door.
The record is the kind I like to look at. Recurring profit went from ¥4,110M to ¥6,316M over five years [F6/F10], never once losing money, and return on equity has run 17.6, 11.6, 15.9, 14.2, 17.1 percent [F47–F51] — good returns, and here is the part that matters, earned with almost no debt. The whole balance sheet carries ¥1,524M of borrowings against ¥15,170M of cash , so the company sits on roughly ¥13.6bn of net cash — about ¥528 a share . Equity ratio 57.7% . When I strip that idle cash out and ask what the operating business earns on the tangible capital it truly uses, I get something like 27% [D21, re-struck ex-cash]. That is not a good business; that is a very good business hiding behind a fortress balance sheet. It throws off cash without needing to eat much — depreciation ¥234M against a capital budget of ¥428M, and ¥190M of even that was buying land for a research lab, not staying in business [F233/F331/E61]. Owner earnings, then, are close to reported net income of about ¥4.4bn.
Now, what would I pay, and what does the market ask? It asks ¥2,354. That is two times book and about thirteen times earnings . My old teacher Ben Graham would have walked right past this — net current assets are ¥569 a share [F161 less F166] against a ¥2,354 price, so it trades at four times net-current-asset value, nowhere near a net-net, and the figures do not hit you over the head with a baseball bat. This is not a cigar butt. If I buy it, I am buying it as a good business at a fair price, and the whole case has to rest on the quality holding up — because at 2× book, there is no asset floor doing my work for me.
So I have to be honest about the quality, and here I get uneasy. The returns are real, but ask why they exist. A genuine franchise is something customers need, can't easily substitute, and where nobody sets your price [B23]. Two-thirds of this business is selling to government bodies whose budgets can be squeezed and whose contracts are competitively bid ; that is a customer relationship, not pricing power. And the moat I can actually point to isn't Ebara Jitsugyo's at all — it's the Ebara agency contract [E3/E57], which gives them the products to sell. That contract auto-renews but expires September 2026, and only extends one year at a time thereafter . The company itself lists losing or shrinking that relationship as a top risk . A moat you rent from someone else, on a one-year rollover, is not the enduring kind I want to own for a decade without a quote. It has held for seventy-five years, which counts for a great deal — but I cannot underwrite it as if Ebara Jitsugyo controls it, because they don't.
The record this year sharpens the worry. The whole jump in profit came from one segment — Engineering profit up 76.8% , on a big opening order backlog burning off — while the Maker segment's profit actually fell . That is a lumpy, project-timing business, not a steady toll bridge, and I'd value it on the cycle, not on the peak year. The dividend tells the same cautious story: this year's ¥120 includes a ¥20 eightieth-birthday one-off , so the sustainable payout is nearer ¥100 pre-split — a real yield closer to 2.1% than the 2.55% on the page .
On the people and the capital, the picture is mixed but mostly reassuring. Management admits its dependence risks in plain language [E36/E38], the auditor has been in place since 1984 with a clean opinion and no going-concern doubt [E94/E137], there are no options, no dilution, no funny footnotes , and they are raising the payout from 35% to 40% and buying back a billion yen of stock [E73/E72]. That is owner-friendly conduct. But two things nag. The founder, born in 1939, is both Chairman and CEO at 86 — one man holding both jobs at that age is a succession question I cannot wave away, even with a capable president beside him . And there is ¥13.6bn of cash plus ¥8bn of securities sitting on the balance sheet earning little; with an activist fund holding 7.58% and 光通信 at 7.90% , the pressure to deploy or return it is real — which cuts both ways. Returned to owners, it's a gift; spent on a full-priced acquisition, it's the institutional imperative at work [B77].
Here is where I come out. This is a genuinely good, understandable business, conservatively financed, run by people who tell the truth and treat owners fairly. It clears the gate and it clears the quality-of-earnings tests. But it is offered at a fair price, not a cheap one — 2× book, ~13× earnings, an owner-earnings yield around 7.7% on the net market cap. That yield is fine, not fat, and the durable edge underneath it is a rented agency contract and a government-budget customer base, neither of which I can promise you about in 2035. When the quality is arguable and the price is merely fair, I don't swing — there are no called strikes. I'd want this at a price where the owner-earnings yield reaches double digits and I'm paying closer to 1.6× book — around ¥1,850 — which also buys me a margin of safety against the day the Ebara contract or the government budget disappoints. Until then, I watch.
Munger
watchInvert first, as always. How does this business die?
The obituary writes itself in one paragraph: Ebara Corporation — the dominant equipment supplier and the source of two-thirds of EJ's merchandise-purchase cost [D23/F308] — declines to renew its agency contract [E36/E57]. It can do this on one year's notice after September 2026 . EJ owns 0.24% of Ebara Corp ; Ebara Corp owns no shares in EJ [E125/E11]. The capital relationship is nil. The commercial relationship is everything. If Ebara reclassifies EJ as a nuisance middleman and goes direct to municipalities, a firm reporting ¥6,316mn recurring profit reverts to something approaching a liquidation of order backlog. That is kill path one. Kill path two: a Japanese government austerity cycle. Two-thirds of sales are to public bodies [D24/F294], and the Engineering segment — the engine of FY2025's 76.8% segment-profit surge [D25/F261] — is 97% public-sector by revenue [E121/F274]. When public-works budgets compress, the backlog drains and EJ's fixed SG&A sits on a shrinking gross profit. Kill path three: founder succession. Chairman Hisashi Suzuki, born November 1939 , is eighty-six years old and holds the combined Chairman-and-CEO role he has occupied since 2020. President Takashi Ishii, born 1962, joined in 1996 and took the COO title in March 2024 — a credible heir in place, but the institutional knowledge and relationship capital embedded in an eighty-six-year-old founder is not transferable by org-chart.
Now the business, plainly stated.
EJ is a privileged distribution agent for the Ebara Group [E7/E11]. It does not make pumps; it sells them, installs water-treatment infrastructure for municipalities, and operates a smaller trading book. The Maker segment — ozone meters, deodorizing units, storage batteries, aquaculture equipment — is genuinely self-developed and fabless , with EJ owning the IP and managing outsourced production. The moat has two distinct layers and I must not conflate them.
Layer one: the Ebara relationship. Ebara Corp is an ¥80bn-capital manufacturer of pumps and water infrastructure. EJ has been its agent since July 1950 — seventy-five years of unbroken commercial entanglement. In practice, the 官公庁 customers who specify Ebara equipment for municipal waterworks reach EJ because EJ is the standing channel. This is a conditioned reflex — the public engineer specifying a new sewage plant calls EJ the way he calls his dentist; the habit precedes any competitive analysis. The fingerprint of a switching-cost moat: no single customer accounts for 10% of consolidated sales [F407/E54], yet ~67% of orders are public-sector with an Engineering backlog of ¥25,084mn building to ¥27,051mn in remaining obligations . Government counterparties do not shop for new distributors; they re-order from the last certified contractor. This is close to a franchise, but it is a borrowed one: the brand belongs to Ebara Corp, not EJ.
Layer two: the Maker segment's own IP. Ozone concentration meters, infection-control products, PFAS-removal filtration — these are genuine EJ inventions. The ozone and medical businesses were recently carved into a dedicated subsidiary [E14/E132] to sharpen focus. R&D runs at ¥735mn annually , expensed in SG&A . This is self-owned moat, but it is small: Maker segment profit was ¥1,247mn in FY2025, down 5% [F259/E48], on ¥7,506mn of revenue .
The figure table is genuinely good. Five-year ROE: 17.62 / 11.55 / 15.93 / 14.20 / 17.06% [F47–F51]. The FY2022 dip to 11.55% shows this is real, cyclical, not confected. Net cash ≈+¥13,646mn against total borrowings of ¥1,524mn [D14/F171] — interest coverage 130× . Asset-light to the point of comedy: investing cash flow was −¥205mn in FY2025 on a ¥41bn revenue base. Capex ¥428mn against depreciation ¥234mn . No bonds, no lease debt on the balance sheet . SG&A grew modestly [F201 vs F200] while gross profit expanded sharply [F90 vs F91], yielding operating margin expansion from 11.3% to 14.9% [D7/D8]. The balance sheet is not cluttered with derivatives or Level 3 mysteries: the non-trivial items are policy-shareholding investment securities (¥8,384mn , primarily the ¥4,036mn Ebara Corp position ) and contract assets from over-time construction revenue (¥11,128mn ). Neither is opaque; the Deloitte KAM audit [E134/E136] focused precisely on the over-time revenue estimates, and the opinion is unqualified . The pension is close to fully funded: obligation ¥2,686mn, assets ¥2,591mn [F391/F392].
What inflated FY2025? Engineering segment profit surged 76.8% because the prior year accumulated a high opening backlog and FY2025 delivered it . Revenue growth from ¥18,872mn to ¥22,450mn [F254/F255] with margin leverage on a near-fixed overhead base produced an outsized profit year. The Maker segment was actually weaker — profit down 5% on higher personnel costs . FY2025 is a record, but it is a record made partly by construction timing, not by a permanent step-change in the earnings power of the franchise. The commemorative ¥20 DPS is non-recurring; strip it and the sustainable yield at ¥2,354 is roughly 2.1%, not 2.55% .
Incentives: executive directors are paid on consolidated operating profit, net income, and ROE . Those are the right three metrics for a capital-light, ROE-oriented business. No EBITDA theater. No options — there are literally no potential dilutive shares . The restricted-stock program grants shares only to insiders and requires holding until retirement . Founder Suzuki holds 2.48% with full skin in the game. The ESOP trust introduces a minor contingent liability: the Company guarantees the trust's bank loan [E69/E70], and ¥514mn of ESOP borrowing sits on the consolidated balance sheet . Trivial relative to ¥13.6bn of net cash.
Governance: the Board is chaired by an independent outside director , and the Nomination Committee — meeting 7 times in FY2025 — explicitly discusses succession planning. Auditor Deloitte has been in place since 1984 with a clean opinion and no going-concern flag. The one governance structure that concentrates power: an 86-year-old founder who is simultaneously Chairman and CEO. President Ishii is clearly the operating successor, but there is no disclosure of when the transition occurs. NIPPON ACTIVE VALUE FUND PLC (AVI-managed) holds 7.58% and Northern Trust (AVFC) 2.99% — likely AVI-related — collectively representing a patient activist voice pushing for capital efficiency improvements. The Feb 2026 buyback authorization (¥1bn / 600,000 shares ) and the payout-ratio upgrade to 40% from FY2026 [F322/E73] read partly as a response to that pressure. That is not a bad thing; it keeps the board focused on per-share value rather than simply accumulating cash.
The valuation: P/E 12.78×, P/B 2.01×, EV/经常利益 6.8× [D1/D2/D19]. For a business earning 17% ROE on clean equity with net cash representing ¥527 per share against a ¥2,354 price, these are not obviously cheap. The opportunity cost question (M35): what else is available? The EV represents payment of roughly 6.8× a cyclically elevated recurring profit — a price that bakes in continued high Engineering margins without reverting. If Engineering segment profit normalizes toward its FY2024 level (¥2,450mn ) and the rest holds flat, consolidated operating profit is closer to ¥4.5bn — implying an EV/operating profit on normalized earnings of roughly 9.5×. That is more than fair, not obviously bargain territory.
The load-bearing question is whether the Ebara agency relationship is a durable privileged position or a revocable license. Seventy-five years of unbroken renewal [E3/E57] is strong evidence. Zero capital ownership tie is the perpetual risk. This business cannot be valued like a brand or a network — it is a structurally dependent agent, not a franchisor. The correct category is "tolerated middleman with strong incumbency." Tolerated middlemen get disrupted when the principal decides the margin it is sharing could be internalized. Nothing in the filings shows Ebara Corp is contemplating this; EJ even holds ¥4,036mn in Ebara Corp shares , a relationship anchor on both sides. But I cannot put a decade-horizon compounding thesis on a contract that renews annually after September 2026 .
The verdict is watch. The business quality is genuine. The price is not clearly wrong. The founder transition is a known unknown, the Ebara contract renewal is a dated cliff, and the FY2025 earnings are elevated by construction timing. At a price that discounts a normalization of Engineering margins and removes the commemorative dividend — something in the ¥1,800–2,000 range on normalized EPS of approximately ¥150 at 12–13× — this becomes a candidate. At ¥2,354 on peak-cycle figures, patience is the rational posture.
There is nothing more to add on the bull case until the agency contract is renewed past 2026, a succession event is disclosed, and Engineering normalizes without a dramatic profit collapse.
Pabrai
watch · buy < ¥1,250Start where Dhandho always starts: what do I lose if I am wrong? Heads I win; tails I don't lose much. Only after that question is answered do I let myself look at the upside.
The balance sheet here is the kind I like to find in Japan. Cash and deposits ¥15,170M against total borrowings of ¥1,524M — no bonds, no lease debt on the sheet — leaves net cash of +¥13,646M , about ¥528 a share gross post-split . Equity ratio 57.7% . Interest coverage 130× . On top of the cash sit listed securities: three policy holdings at ¥4,236M (the biggest is 1.1M Ebara Corp shares, ¥4,036M [E102/F316]) plus four pure-investment listed names at ¥3,988M carrying a ¥3,800M unrealized gain — call it ~¥8.2bn of marketable stock, marked to market. So before I value the operating business at one yen, I have net cash of ¥13.6bn and, haircutting the securities 20-25%, another ~¥6bn — roughly ¥20bn of liquid assets against a ¥56.6bn net market cap . That is ~36 cents of every purchase yen sitting in cash and quoted stock. This is the IKEA-never-took-debt profile Munger and Buffett taught me to prize: the single biggest reason businesses die is leverage, and this one simply cannot be killed by a lender's mood. P20 and its whole survival family (P23-P31) pass without a fight — two lost years would leave the company still cash-rich, still paying dividends, still buying back stock.
So the "tails" branch is real and hard. But here is the discipline: an asset floor is not the same as a fifty-cent dollar. At ¥2,354 the stock trades at 2.01× book and 12.78× earnings , EV/経常利益 6.8× . My hard floor — net cash plus haircut securities — is maybe ¥900-1,100 a share; book value is ¥1,172 . So if the market re-rated this to its asset backing, I'd lose roughly a third to a half of my money. That is not "I don't lose much." The downside is cushioned, not absent. Papa Patel's motel had non-recourse debt so his worst case was losing one motel's equity; here my worst case is a de-rating to book on a business whose earnings turn out to be less durable than they look. Survivable, but not the -20% floor against a 2-3x upside that P2 and P53 demand.
Now the business, in five plain sentences (P50). EBARA JITSUGYO designs and builds water-treatment plants for Japanese city and prefectural governments (エンジニアリング, ~66% of sales to 官公庁 ), sells self-designed environmental gear it has contract-manufactured because it owns no factories (メーカー, fabless ), and trades Ebara-Group pumps and HVAC to private buyers (商社). It is the distribution agent for Ebara Corp , buying ~67% of its merchandise and ~19% of its construction materials from that group. It makes money on engineering margin and trading spread; customers stay because water infrastructure is aging, disaster-resilience spending is rising , and public buyers reorder. That I can explain — it clears the circle-of-competence gate (P68) on simplicity. It is a slow-changing industry (P55): a sewage plant in 2005 looks like a sewage plant today.
The load-bearing worry is P18 — cyclical trough vs. what I'm actually being handed, which is the opposite: a record year. FY2025 was the best in the company's history — 経常利益 ¥6,316M versus ¥4,110M four years earlier , operating profit +44% — and it was driven almost entirely by one segment: Engineering profit +76.8% [D25/F261], on a high opening order backlog burning off smoothly . Maker was down 5% and Trading up 8% [E48/E49] — roughly flat. So I am not buying a distressed business in a distressed industry (P16 fails — there is no fire in this theater, no fearful seller). I am being offered a good business at a full-ish price at the top of its own earnings arc. Pabrai's rule on normalized earnings (P56) bites hard here: the ROE series (17.6/11.6/15.9/14.2/17.1% [F47-F51]) shows FY2022 dropping to 11.6% and 経常利益 falling to ¥2,929M — this stream breathes. Value the company on ¥6.3bn of 経常 and it's cheap-ish; value it on a mid-cycle ¥4.5-5.0bn and 13× trailing earnings is really ~16-18× normalized. That is not a bargain; that is fair value for quality.
What I am paid for while I wait (P17) is genuine: net cash compounding, a dividend (¥60 split-adjusted, 2.55% — though ¥10 of it is an 80th-anniversary one-off , so the durable yield is ~2.1%), a payout ratio rising 35%→40% [F322/F323], and a fresh ¥1.0bn buyback [E72/F344] shrinking a share count already carrying 6.94% treasury . And there is a real activist on the register — Nippon Active Value Fund 7.58% , plus what looks like an AVI-related Northern Trust line at 2.99% — which is my P35 superinvestor-precedent tell (13F doesn't cover Japan; the EDINET 5% holder is the analog). That is a documented value investor already here, and light pressure on an 87-year-old founder-chairman-and-CEO to keep returning the cash pile.
But cloning (P32) and the moat-in-the-numbers test (P57) are where I hesitate to pay up. The excess returns come from a real arbitrage — an incumbent agency relationship with Ebara plus decades of public-sector qualification — but it is an agency, and the basic agency contract expires 2026-09-30 with only a one-year auto-extension . The two-sided dependence (67% of purchases from one supplier group ; 66% of sales to budget-constrained governments ) is exactly the kind of concentration that P12 flags — mitigated here because no single customer is 10% and the supplier tie is 75 years old, but structural. This is a fine, well-run, unkillable little compounder. It is not, at 2× book and a record-year multiple, a fifty-cent dollar.
Verdict: watch. The downside is cushioned by a hard net-cash-and-securities floor, so this is not a pass — nothing here can permanently impair capital. But the discount is not wide enough for a big Dhandho bet, and I'm being asked to pay a full multiple on peak earnings. Few bets, big bets, infrequent bets (P66): this one doesn't clear the bar at ¥2,354. It clears it in the ¥1,000s, where net cash and securities cover most of the price and I'm buying the water franchise nearly for free.
Li Lu
watch · buy < ¥1,650Let me begin where I always begin: not with the price, but with the question of whether I can honestly say I understand this business's next ten years better than most of the people who own it. Everything downstream — the two-times-book, the thirteen-times-earnings, the fortress balance sheet — is idle until that question is answered, because no price rescues a business you cannot predict.
The business is unusually legible, which I respect. Ebara Jitsugyo sells and builds water and environmental infrastructure through three segments — a fabless equipment Maker , an Engineering arm that takes public-sector orders directly and builds water-treatment plants , and a Trading arm — and it is a distribution agent (販売代理店) for the Ebara Group . The economics are genuinely good and genuinely durable on the face of the record: ROE 17.62 / 11.55 / 15.93 / 14.20 / 17.06% over five years [F47-F51], recurring profit compounding ¥4,110M to ¥6,316M [F6-F10], equity ratio 57.7% , and a balance sheet carrying net cash of roughly ¥13.6bn against a market capitalization net of treasury near ¥56.6bn . Investing cash flow of minus ¥205M tells you this is an asset-light business — it earns its returns on almost no plant. The auditor has been Deloitte continuously since 1984, the opinion is unqualified, there is no going-concern doubt, and the single Key Audit Matter is the percentage-of-completion accounting on construction contracts [E94, E134, E137]. There are no related-party transactions , Ebara is explicitly not a parent , and no single customer is 10% of sales . This is a clean, honest set of books run by people who, on the evidence of the trail, treat the balance sheet conservatively.
So can I predict the earnings ten years out (L1)? The decisive variables are two, and here is where my honesty must do its work. First, the public-sector water-infrastructure spend: about 66% of sales and 67% of orders go to 官公庁 [D24, D31], and management itself frames the market as two opposing vectors — aging-water-infrastructure and disaster-resilience demand pulling up, population decline pulling down [E24, E23]. Second, the Ebara agency relationship: ~67% of merchandise purchases and ~19% of product/construction COGS are Ebara-sourced [D23, D22], under a basic agency contract that, the filing states plainly, auto-extends "for only one year after 2026-09-30" . I can map each variable to a disclosure — that part of L1 passes. What I cannot do is answer them with the confidence Li Lu's standard demands. The aging-infrastructure tailwind is real and structural, but the counter-vector (population decline) and the fact that the customer is a government budget line means the demand is not something the company controls or prices — it is appropriated. And the Ebara contract is the hinge of the whole enterprise: is this a privileged, decades-old agency moat, or a dependency whose renewal I am quietly assuming? The filing gives me a renewal date, not a renewal guarantee.
That forces the honest ledger (L4). The verdict cannot rest on anything I am pretending to know, and two load-bearing inputs — Ebara renewing on comparable terms, and public budgets holding — are assumptions, not verified facts. Li Lu's discipline is that the acknowledged unknowns must be absorbed by the purchase price (L5): at 2× book with the balance sheet cash-heavy, the price is not distressed enough to pre-absorb a bad resolution of either. This is not Timberland, where the feared exposure was under 5% of earnings and the stock was priced for disaster. Here the feared exposures are the majority of the revenue base, and the stock is priced for a good, well-run compounder — fairly, not fearfully.
Now the compounding case, honestly stated, because it is the reason this is a watch and not a pass. Is intrinsic value growing or melting (L35)? Growing: book value per share compounded ~10.6% p.a. over the window , the ROIC proxy sits near 14.8% — and would be materially higher stripped of the ¥13.6bn idle cash — and management's capital allocation is the virtue I prize most. They raised the payout target from 35% to 40% , authorized a fresh ¥1.0bn buyback , carry no empire-building goodwill, and stayed inside their circle for eighty years. The four-part gate (L50): superior company economics — yes; superior industry economics — partly (public works is stable but not a great business, and the Engineering swing that drove +76.8% this year was backlog timing , not a step-change in moat); good management — yes, on the trail of actions; right price — not yet with a margin of safety. Note too the quality wrinkles: FY2027 operating profit is guided below FY2026 in the company's own plan [F411, F412], and operating cash flow was only ¥1,413M against ¥4,384M of net income [F61, F220] because contract assets swelled ¥3,157M — the profits are real but the cash conversion is lumpy and I would want several more years to trust the through-cycle figure (L48).
Two structural notes close the picture. The Asia lens (L26): policy cross-holdings of three listed issues, ¥4,236M, the largest being Ebara itself [E101, E102] — a governance blemish, though modest and shrinking, and an activist (AVI's Nippon Active Value Fund, 7.58% ) is already present to press capital efficiency. And the key-man fact I will not wave away: the founder, born 1939, is Chairman and CEO , with a 63-year-old COO beneath him . For a ten-year owner, that is a real succession unknown that the filings do not resolve.
Claude
watchMy §1 priors, registered figures-blind, held up almost verbatim — which is the point of registering them first. I put P(watch) at 0.35 as the single most probable landing spot, with the tension pre-committed: "good business, right direction of travel, but priced too close to fair value to demand today." The ledger confirms every load-bearing prior and overturns none of the important ones.
What the ledger confirmed. (1) Quality is real, not a peak illusion at the ROE line. ROE ran 17.62 / 11.55 / 15.93 / 14.20 / 17.06% across FY2021–25 [F47–F51], recomputing cleanly to 17.06% ; no loss year, on a 57.7% equity ratio . This is a durably high-return business — my "durable-return" class trait [C1] survives. (2) Net cash is a genuine cushion, the opposite of a levered residual. +¥13,646M (cash 15,170 − borrowings 1,524 ; no bonds, no BS lease debt), 24% of the ¥56.6bn net market cap . (3) Asset-light is confirmed to the yen: 投資CF −¥205M , depreciation ¥234M , 有形固定資産 only ¥3,269M . (4) The moat is borrowed, my H1 gate: ~67.0% of merchandise purchases are Ebara-sourced [F304/D23], the basic agency contract auto-extends only ~one year past 2026-09-30 , and ~66.3% of sales go to 官公庁 [F294/D24]. (5) The record year is Engineering-peak-flattered, my margin/cycle prior [C9/C40]: consolidated OP rose +44% almost entirely on Engineering segment profit +76.8% (2,450→4,332) [F260/F261/D25], driven by "a high opening order backlog" — Maker was −5.0% and Trading +7.6% [F259/F263]. Management's own EJ2027 guide then puts FY2027 OP (¥5,500M ) below FY2026 (¥6,300M ) — an explicit admission the peak recedes. (6) The commemorative dividend flatters the headline yield: FY2025 DPS ¥120 includes a ¥20 80th-anniversary payment [F324/E74]; the recurring post-split yield is ~2.1% [ex-commem ~¥50], not 2.55% . (7) The activist nudge and the founder key-man both exist: NIPPON ACTIVE VALUE FUND 7.58% (+ Northern Trust/AVFC 2.99% ) and 光通信 7.90% on the register; Chairman and CEO Hisashi Suzuki, b.1939 (86), holds both roles , with a younger President/COO and a monitored succession plan .
What the ledger sharpened rather than overturned. My H1 prior said "borrowed until proven owned." The read is more precise: the moat is mostly borrowed (the selling right and the demand base are both rented) but carries some owned elements — direct 官公庁 incumbency, the ~70-firm Ginsuikai subcontractor network , design IP behind self-developed products , and a 75-year relationship no entrant replicates quickly . Owned enough to earn 15%+ ROE; not owned enough to underwrite the peak as permanent, and exposed at a contract renewal it does not control.
The forensic read. Incremental margin (C13) FY2024→25 = ΔOP 1,870 [F87−F88] ÷ Δrev 3,708 [F5−F4] = 50.4%, far above the ~14.9% average — but that is the backlog-conversion peak, not a durable scale economy; read with C40 it flags "earnings high," not "moat widening." Accrual/cash conversion (C23): 5-yr CFO ¥12,855M vs NI ¥16,010M = 80% — below 90%, but the driver is benign and disclosed: receivables & contract assets +¥3,157M as Engineering backlog converted (contract assets ¥7,856→11,128M ), a percentage-of-completion timing feature , not accrual manipulation. It does mean reported earnings run ahead of cash in growth years — a reason to normalize down, not to distrust. One-off scan (C30): the ¥20 commemorative dividend is the salient recurring-"special" ; FY2025 also carried ¥199M securities impairment [F211/F406] and ¥103M securities-sale gain — small, roughly offsetting, non-operating. The sole KAM is over-time construction-revenue recognition — the one place estimates could flatter profit, and the auditor's ranked concern. Segment cross-subsidy (C21): no destroyer — all three segments earn (Maker 1,247 / Eng 4,332 / Trading 1,883 [F259/F261/F263]); the corporate line is a −¥1,342M unallocated cost , not a loss-making division. Disclosure subtraction (C25/C32): nothing material vanished in this single-year read; the segment structure is stable at three .
Owner arithmetic (the deciding work). I value the whole company as a private buyer, downside first.
Bear case, valued first (C33), each assumption from observed history. The FY2022 trough printed net income ¥2,169M on recurring ¥2,929M at a 9.7% recurring margin — a −7% revenue year . A realistic bear un-does the Engineering peak (seg profit reverts ¥4,332→2,450 [F261/F260], ≈−¥1,880M consolidated) and lets margins revert: normalized bear net income ≈ ¥2,400M. Capitalized at 9% no-growth = ¥26.7bn operating value + full net cash ¥13.6bn = ¥40.3bn ÷ 24.06M net-float shares = ≈¥1,675/share — a −29% draw from ¥2,354, cushioned (not eliminated) by real cash. The absolute-catastrophe floor is net cash ¥567/sh (net float) [D15 note] and the ¥1,172.56 book is not fully realizable (much is working-capital contract assets and the illiquid Ebara stake).
Reverse-DCF on ¥2,354 (C34). EV ¥43.0bn . Mid-cycle NOPAT ≈ recurring-avg ¥4,392M [F6–F10 avg] × (1−0.288) ≈ ¥3,127M; no-growth EPV at 9% = ¥34.7bn + net cash ¥13.6bn = ¥48.4bn, i.e. ~¥2,011/share — the stamp sits above mid-cycle no-growth intrinsic at 9% (and above it at 8%→¥2,191, 10%→¥1,867). So the price embeds either near-peak earnings held with no growth, or mid-cycle earnings plus ~1.5–2%/yr perpetual growth. Against the reference-class base rate (margins revert, growth decays; C2/C5/C9), that implied path is fair, not cheap — and it is harder to beat than a bargain would require, exactly my §1 price prior [H2].
Private-owner yield, multiple-free (C35). Normalized owner earnings ≈ ¥3,400M (mid-cycle net income ~¥3,200M [F11–F15 avg], nudged for genuine growth; maintenance capex ≈ depreciation ¥234M, so owner earnings ≈ net income — the ¥190M research-land capex is growth/one-off). Against market cap net of ~¥11bn deployable cash (C47 haircut from ¥13.6bn for ¥646M restricted deposits + seasonal Dec–Mar working-capital buffer ): ¥3,400M ÷ ¥45.6bn = 7.4%. Below a ~9% equity hurdle for a borrowed-moat, budget-dependent small-cap. Only on FY2025 peak earnings (¥4,384M) does the yield reach 9.6% and clear. That is the whole verdict in one line: the owner yield clears only if you credit the peak you were just told recedes.
Earnings-power vs asset value (C38). EPV of operations (mid-cycle, no growth, 9%) ≈ ¥34.7bn > reproduction value of the operating assets (adjusted book ex-surplus-cash-and-securities is modest — the firm is fabless). EPV above asset value is a franchise claim; here it is defensible (15%+ ROE, real incumbency) but partly rented — so I discount it rather than capitalize it fully.
Securities & the Ebara stake (C48/C55). Investment securities ¥8,384M : the ¥4,036M Ebara holding is strategic — held expressly to protect the agency , no realization path, counted at zero deployable value. Pure-investment ¥3,988M with ¥3,800M unrealized gain marks to ≈¥2,848M after ~30% tax, and is being trimmed — a modest real add, already inside the deployable-cash cushion.
Implied buy-below (C44), derived blind to the stamp. The price at which the bear-case owner yield clears the hurdle: bear net income ¥2,400M ÷ 0.09 = ¥26.7bn operating value + deployable net cash ¥11bn = ¥37.7bn ÷ 24.06M = ≈¥1,600/share. At ¥1,600 the bear case yields 8.7% (≈hurdle) and mid-cycle yields 12.4% (strong margin of safety). This lands ~32% below the ¥2,354 stamp — comfortably outside the ±15% anchor band (C89), so it is arithmetic, not anchor gravity. P(private-owner yield clears the hurdle at/below ¥1,600) ≈ 0.75.
Verdict: watch. At ¥2,354 — 2.01× book , 12.78× peak earnings , EV/経常 6.8× on the peak but 9.8× on mid-cycle recurring — this is a genuinely good, clean, net-cash, capital-returning business (payout 35%→40% from FY2026 [F322/F323], a new ¥1bn/600k-share buyback running ) whose quality my priors under-, not over-, weighted. It is not a pass: the downside is real (−29%) but survivable and cash-cushioned, the capital-return trajectory is executing, and an activist sits on the register — a pass would understate all three. It is not a buy here: the private-owner yield does not clear the hurdle on normalized earnings, the moat is borrowed at a contract the firm does not control, and I would be paying a full price for a peak year management itself guides down. It is a watch — the right verdict when a good business is offered at a fair price: name the price I would own it at (¥1,600, ~32% lower), and the observable that flips it. It is not too-hard: the price question decides the verdict at ¥2,354 before the genuine unknowables (agency renewal past ~2027, founder succession) become load-bearing — those are reasons for the discount I demand, which is precisely a watch.
If this was worth your time
One Japanese company at a time, reasoned in public — no tips, just the thinking. If that's useful to you, two things genuinely help, and both take ten seconds: